Form 4: DXP Enterprises Director David Patton Receives Future-Dated Equity Award
Insider Transaction Report
DXP Enterprises Director David Patton was granted 917 shares of common stock on July 1, 2025, as an equity award, vesting one year from the grant date, under a Rule 10b5-1 plan.
Summary
- David Patton, a Director of DXP Enterprises Inc. (DXPE), received an equity award of 917 shares of DXP Common Stock.
- The transaction date for this acquisition was July 1, 2025.
- The shares were acquired at a price of $90.04 per share.
- Following this transaction, David Patton beneficially owns 24,344 shares of DXP Common Stock.
- The grant provides for full vesting one year from the date of grant, which is July 1, 2025.
- The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 7
Explanation: The document reports a routine equity grant to a director, which is generally positive as it aligns management/director interests with shareholders. There are no negative implications.
Positives
- Director David Patton received an equity award, aligning his interests with shareholders.
- The grant was made under a Rule 10b5-1 plan, indicating a pre-arranged and transparent transaction.
Future Outlook
The shares granted on July 1, 2025, are scheduled for full vesting one year from that date.
Industry Context
This is an insider transaction report, common across all industries for publicly traded companies. It reflects standard compensation practices for directors.
Comparison to Industry Standards
- Equity awards to directors are a common practice in publicly traded companies across various industries, aligning director incentives with shareholder value.
- The specific size of the award (917 shares) and price ($90.04) would need context from DXP's compensation policies and peer group comparisons to assess against industry standards, which are not provided in this document.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy/Procedure | The transaction was made under a Rule 10b5-1 plan, which is a corporate governance mechanism for pre-arranged stock trades by insiders to avoid accusations of insider trading. | 07/01/2025 | Enhances transparency and reduces potential for insider trading concerns related to this specific transaction. |
Related Party Transactions
- The equity award to Director David Patton constitutes a related party transaction, which is a standard practice for director compensation.
Stakeholder Impact
- Shareholders: The equity award aligns the director's interests with shareholders, potentially encouraging decisions that enhance shareholder value.
Next Steps
- Full vesting of the 917 shares is expected one year from July 1, 2025.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Grant date for 917 shares of DXP Common Stock Award to David Patton, with full vesting one year from this date. |
| 07/02/2025 | Date the Form 4 was filed. |
Recommendation
holdKeywords
DXP Enterprises, DXPE, Form 4, insider transaction, equity award, stock grant, David Patton, director, Rule 10b5-1, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.